Funder: European Commission
Due Dates: September 15, 2026 (Full application, single-stage, 17:00 Brussels time)
Funding Amounts: €15,000,000 total; one project funded; lump sum grant; typical project duration 4–5 years
Summary: Funds development and validation of microbiome-based tools for early, personalized cancer prediction and prevention before disease onset, supporting EU Cancer Mission goals.
Key Information: Single project will be selected; strong focus on multi-cohort collaboration, AI risk modeling, and clinical validation.